---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-419174"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2026-10-09T20:42:27+00:00"
generated_at: "2026-10-12T15:04:30.195598+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte raises ~$1.10B via concurrent offerings: $575M 1.50% converts due 2032 and $64/share stock sale

## Summary
- $575M aggregate 1.50% convertible senior notes due Oct 15, 2032; initial conversion price ~$89.60/share (11.1607 shares per $1,000); $75M over-allotment exercised in full.
- Equity offering of 7,412,500 shares at $64.00 plus 400,000 pre-funded warrants at $63.999; underwriters' 30-day option for 1,171,875 more shares exercised in full.
- Net proceeds ~$544.3M from the equity sale and ~$558.7M from the notes after discounts and expenses; both offerings closed Oct 9, 2026.
- Interest on the notes payable semi-annually Apr 15 and Oct 15, starting Apr 15, 2027; provisional redemption permitted on/after Oct 22, 2029 if the stock tops 130% of conversion price.
- Jefferies LLC and Leerink Partners LLC led both deals; notes are senior unsecured obligations under an indenture with U.S. Bank Trust Company as trustee.

## SEC filing metadata
- accession: 0001193125-26-419174
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2026-10-09T20:42:27+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000119312526419174/0001193125-26-419174-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000119312526419174/d150490d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-419174
- JSON: https://secwatch.observer/filing/0001193125-26-419174.json
- Plain text: https://secwatch.observer/filing/0001193125-26-419174.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.